Skip to main content

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 1 open-market purchase and 5 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 17, 2026
$148.6M
Insider buysLast 90 days, $34.3K in total
1
Insider sellsLast 90 days, $296.4K in total
5
13F holdersQ2 2026, +19 vs. previous quarter
126
13F valueReported value at the end of Q2 2026
$243.3M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$5.82M
+37.1% year over year
Net income, FY2025
$71.2M
No comparable prior period
Free cash flow, FY2025
-$84.3M
No comparable prior period
Revenue, Q3 FY2026
$13.5M
No comparable prior period

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net income for FY2025: $71.2M (1223.1% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
16.9M
Shares sold short
Change
−335.0K
−2.0% vs. previous
Days to cover
21.67
At average daily volume

Superinvestors holding ABEO, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding ABEO at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Abeona Therapeutics Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 16, 2026 (view filing)8:00 AM ETNov 133 daysCharles Faith L.DirectorPPurchase+15.0K$2.29+$34.3K+8.5%191.4K after
Sep 29, 2026 (view filing)9:48 PM ETSep 29Same daySeshadri VishwasChief Executive OfficerSSale−19.6K$5.16−$101.1K−1.5%1.29M after
Sep 29, 2026 (view filing)9:48 PM ETSep 29Same dayVazzano Joseph WalterChief Financial OfficerSSale−9.19K$5.16−$47.4K−1.9%482.9K after
Sep 29, 2026 (view filing)9:48 PM ETSep 29Same dayO'Malley Brendan M.SVP, Chief Legal OfficerSSale−6.73K$5.16−$34.7K−1.6%421.2K after
Sep 29, 2026 (view filing)9:47 PM ETSep 29Same dayVasanthavada MadhavChief Commercial OfficerSSale−4.90K$5.16−$25.3K−1.7%285.7K after
Sep 1, 2026 (view filing)5:48 PM ETSep 1Same dayAlvino MarkDirectorSSale−15.0K$5.86−$88.0K−19.5%62.1K after
Jul 22, 2026 (view filing)4:30 PM ETJul 211 dayVazzano Joseph WalterChief Financial OfficerSSale−1.48K$6.53−$9.65K−0.3%492.1K after
Jul 9, 2026 (view filing)7:24 PM ETJul 9Same dayVazzano Joseph WalterChief Financial OfficerSSale−24.9K$6.96−$173.3K−4.8%493.6K after
Jul 9, 2026 (view filing)7:22 PM ETJul 9Same daySeshadri VishwasChief Executive OfficerSSale−68.0K$6.96−$473.3K−4.9%1.31M after
Jul 9, 2026 (view filing)7:20 PM ETJul 9Same dayO'Malley Brendan M.SVP, Chief Legal OfficerSSale−12.1K$6.96−$83.9K−2.7%428.0K after

Top 10 13F holders, Q2 2026

See all 126 holders

The largest institutional positions in Abeona Therapeutics Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding ABEO in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Nantahala Capital Management, LLC5,136,490$31.7M1.92%+123,438+2.5%Added
BlackRock, Inc.3,352,474$20.7M0.00%+156,944+4.9%Added
Cable Car Capital LLC3,007,329$18.6M0.40%00.0%Unchanged
AIGH Capital Management LLC2,987,000$18.5M1.67%−113,000−3.6%Reduced
Vanguard Capital Management LLC2,211,433$13.7M0.00%+46,582+2.2%Added
Resources Investment Advisors, LLC.1,653,024$10.2M0.09%+1,653,024New
AWM Investment Company, Inc.1,486,130$9.18M0.80%+683,000+85.0%Added
Geode Capital Management, LLC1,261,090$7.80M0.00%+51,293+4.2%Added
Kennedy Capital Management, Inc.1,240,071$7.66M0.14%−23,440−1.9%Reduced
Goldman Sachs Group Inc1,224,806$7.57M0.00%+94,187+8.3%Added

Holders of 5% or more of ABEO

See all 9 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Abeona Therapeutics Inc..

Largest holders of ABEO from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Nantahala Capital Management, LLC13G/A9.99%5.78M shares0.00 ppfrom 9.99%Feb 14, 20236 filingsMay 15, 2026SEC
Funicular Funds, LP13G/A7.50%5.10M shares+2.20 ppfrom 5.30%Apr 6, 20262 filingsNov 13, 2026SEC
Kaufman Daniel Louis13G/A7.30%4.16M shares+2.14 ppfrom 5.16%Mar 27, 20262 filingsNov 12, 2026SEC
TPG GP A, LLC13G7.00%4.76M sharesNewNov 16, 20261 filingNov 16, 2026SEC
James Russell Revocable Trust13D6.10%3.48M shares+0.80 ppfrom 5.30%Sep 30, 20252 filingsOct 23, 2026SEC